TABLE 2—

US State-Level Neonatal Abstinence Syndrome and Perinatal Substance Exposure Surveillance Activities by Reporting Requirements and Use of Clinical Case or Surveillance Definitions: July and December 2018

Activity or Type of Definitions	No. of States	States
Any NAS or perinatal substance exposure–related surveillance and data activities	44	AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NH, NJ, NM, NY, NC, ND, OH, OK, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI
NAS or perinatal substance exposure reportable condition	9	AZ, FL, GA, KY, MA, OH, PA, TN, VA
Clinical case definition only	7	AZ, GA, IN, KY, PA, TN, WV
Surveillance definition only	22	AK, CA, CO, CT, FL, IA, KS, LA, ME, MA, MI, MN, MS, MO, MT, NM, NY, OK, RI, SD, VT, WI
Clinical case definition and surveillance definition	3	DE, OH, VA
Surveillance activities with unspecified surveillance definition	10	AL, AR, MD, NH, NJ, NC, ND, SC, TX, WA
Clinical case definition and unspecified surveillance definition	2	IL, UT
No identified activities	6	HI, ID, NE, NV, OR, WY

Note. NAS = neonatal abstinence syndrome. Results are from information gathered from publicly available, Web-based sources. Researchers did not directly contact states to confirm or obtain additional information regarding activities, reporting requirements, or definitions. Additionally, categories are not mutually exclusive. States can be included in more than 1 category.